His scientific interests lie mostly in Cell biology, DNA damage, DNA repair, Cancer research and Cell cycle. His biological study spans a wide range of topics, including Genetics, Replication protein A, Genotoxic Stress, Chromatin and MRN complex. His DNA damage research integrates issues from G2-M DNA damage checkpoint, Carcinogenesis and DNA replication.
Jiri Bartek has researched G2-M DNA damage checkpoint in several fields, including CHEK1 and Checkpoint Kinase 2. He interconnects Mutation and Molecular biology in the investigation of issues within DNA repair. His research in Cancer research intersects with topics in Tumor suppressor gene and Gene, Locus.
Jiri Bartek mainly investigates DNA damage, Cell biology, Cancer research, DNA repair and DNA replication. He combines subjects such as Carcinogenesis, Molecular biology, G2-M DNA damage checkpoint and CHEK1 with his study of DNA damage. His Cell biology research incorporates themes from Chromatin, DNA and Cell cycle.
His study in Chromatin is interdisciplinary in nature, drawing from both Histone, Ubiquitin and MDC1. Jiri Bartek has researched Cancer research in several fields, including Cancer cell, Cancer, Breast cancer, Apoptosis and Immunology. His biological study spans a wide range of topics, including Transcription and Homologous recombination.
His main research concerns Cell biology, DNA damage, DNA replication, Cancer research and Cancer. His Cell biology study integrates concerns from other disciplines, such as Plasmon, DNA, DNA repair and Genome instability. Jiri Bartek combines subjects such as Chromatin and Transcription with his study of DNA repair.
His Genome instability research integrates issues from Cell cycle and Cell growth. Jiri Bartek integrates many fields, such as DNA damage and Premature aging, in his works. His Cancer research study combines topics from a wide range of disciplines, such as Cancer cell, Apoptosis, Kinase, Bone marrow and Demethylating agent.
His primary areas of study are Cell biology, Cancer research, Cancer, Artificial intelligence and Precision medicine. His research in Cell biology intersects with topics in Carcinogenesis, Transcription, Autophagy and DNA repair. The study incorporates disciplines such as A549 cell, Metabolite, Cytotoxicity, Aldehyde dehydrogenase and In vivo in addition to Cancer research.
His Cancer research incorporates elements of Artificial neural network, Deep learning, Deep neural networks and Response to therapy. His Artificial intelligence research includes elements of Machine learning, Pharmacogenomics and Data mining. Jiri Bartek has included themes like Association rule learning and Process in his Precision medicine study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The DNA-damage response in human biology and disease
Stephen P. Jackson;Jiri Bartek.
Cell-cycle checkpoints and cancer
Michael B. Kastan;Jiri Bartek.
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jirina Bartkova;Zuzana Horejsí;Karen Koed;Alwin Krämer.
The causes and consequences of genetic heterogeneity in cancer evolution.
Rebecca A. Burrell;Nicholas McGranahan;Nicholas McGranahan;Jiri Bartek;Charles Swanton.
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova;Nousin Rezaei;Michalis Liontos;Panagiotis Karakaidos.
An oncogene-induced DNA damage model for cancer development.
Thanos D. Halazonetis;Vassilis G. Gorgoulis;Jiri Bartek.
Chk1 and Chk2 kinases in checkpoint control and cancer.
Jiri Bartek;Jiri Lukas.
Cancer Cell (2003)
Human CtIP promotes DNA end resection
Alessandro A. Sartori;Claudia Lukas;Julia Coates;Martin Mistrik.
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Jacob Falck;Niels Mailand;Randi G. Syljuåsen;Jiri Bartek.
Increased expression of mutant forms of p53 oncogene in primary lung cancer.
R Iggo;K Gatter;J Bartek;D Lane.
The Lancet (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: